耿亮,章航,张奇

• 1:上海市东方医院心脏内科

摘要(Abstract)：

冠状动脉粥样硬化斑块愈合是斑块致栓后经血栓溶解机化、肉芽组织增生及再内皮化后，重塑血管结构稳定的病理生理过程。其临床意义呈现显著的“双刃剑”特征，既是急性冠状动脉综合征下的修复机制，又可能因修复失衡导致管腔狭窄进展。本文系统综述斑块愈合的过程机制、临床意义及干预策略，旨在为心血管病的防治提供新思路。

关键词(KeyWords)： 冠状动脉粥样硬化;斑块愈合;光学相干断层成像

Abstract:

Keywords:

基金项目(Foundation): 上海市浦东新区卫生系统重点学科群建设资助项目（PWZxq2022-02）

作者(Author): 耿亮,章航,张奇

参考文献(References)：

• [1]Dimitriadis K,Adamopoulou E,Pyrpyris N,et al.Coronary plaque healing:a safety net or a hazard indicator[J].J Thromb Thrombolysis,2026,59(1):76-94. DOI:10.1007/s11239-025-03152-9.
• [2]Tomaniak M,Katagiri Y,Modolo R,et al.Vulnerable plaques and patients:state-of-the-art[J].Eur Heart J,2020,41(31):2997-3004.DOI:10.1093/eurheartj/ehaa227.
• [3]Erlinge D,Maehara A,Ben-Yehuda O,et al.PROSPECTⅡ investigators. identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound(PROSPECT Ⅱ):a prospective natural history study[J]. Lancet,2021,397(10278):985-995. DOI:10.1016/S0140-6736(21)00249-X.
• [4]Burke AP,Kolodgie FD,Farb A,et al.Healed plaque ruptures and sudden coronary death:evidence that subclinical rupture has a role in plaque progression[J].Circulation,2001,103(7):934-940.DOI:10.1161/01.CIR.103.7.934.
• [5]Mann J,Davies MJ.Mechanisms of progression in native coronary artery disease:role of healed plaque disruption[J].Heart,1999,82(3):265-268. DOI:10.1136/hrt.82.3.265.
• [6]Yonetsu T,Jang IK.Cardiac optical coherence tomography:history,current status,and perspective[J]. JACC Asia,2023,4(2):89-107. DOI:10.1016/j.jacasi.2023.10.001.
• [7]Shimokado A,Matsuo Y,Kubo,T,et al.In vivo optical coherence tomography imaging and histopathology of healed coronary plaques[J].Atherosclerosis,2018,275:35-42. DOI:10.1016/j.atherosclerosis.2018.05.025.
• [8]Jinnouchi H,Guo L,Sakamoto A,et al.Diversity of macrophage phenotypes and responses in atherosclerosis[J].Cell Mol Life Sci,2020,77(10),1919-1932. DOI:10.1007/s00018-019-03371-3.
• [9]Waring OJ,Skenteris,NT,Biessen EAL,et al.Two-faced janus:the dual role of macrophages in atherosclerotic calcification[J]. Cardiovasc Res,2022,118(13):2768-2777. DOI:10.1093/cvr/cvab301.
• [10]Russo M,Fracassi F,Kurihara O,et al.Healed plaques in patients with stable angina pectoris[J].Arterioscler Thromb Vasc Biol,2020,40(6):1587-1597. DOI:10.1161/ATVBAHA.120.314298.
• [11]Vergallo R,Porto I,D'Amario D,et al.Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability:an in vivo optical coherence tomography study[J].JAMA Cardiol,2019,4(4):321-329. DOI:10.1001/jamacardio.2019.0275.
• [12]Yamamoto MH,Yamashita K,Matsumura M,et al.Serial 3-vessel optical coherence tomography and intravascular ultrasound analysis of changing morphologies associated with lesion progression in patients with stable angina pectoris[J].Circ Cardiovasc Imaging,2017,10(9):e006347.DOI:10.1161/CIRCIMAGING.117.006347.
• [13]Araki M, Yonetsu T, Kurihara O, et al. Predictors of rapid plaque progression:an optical coherence tomography study[J]. JACC Cardiovasc Imaging, 2021 ,14(8):1628-1638. DOI:10.1016/j.jcmg.2020.08.014.
• [14]Fracassi F,Crea F,Sugiyama T,et al. Healed culprit plaques in patients with acute coronary syndromes[J].J Am Coll Cardiol,2019,73(18):2253-2263. DOI:10.1016/j.jacc.2018.10.093.
• [15]Niida T,Kinoshita D,Suzuki K,et al.Layered plaque is associated with high levels of vascular inflammation and vulnerability in patients with stable angina pectoris[J].J Thromb Thrombolysis,2024,57(6):880-887. DOI:10.1007/s11239-024-02982-3.
• [16]Otsuka F,Yasuda S,Noguchi T,et al.Pathology of coronary atherosclerosis and thrombosis[J].Cardiovasc Diagn Ther,2016,6(4):396-408. DOI:10.21037/cdt.2016.06.01.
• [17]Nishihira K,Shibata Y,Yamashita A,et al.Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction[J].Atherosclerosis,2018,268:138-144.DOI:10.1016/j.atherosclerosis.2017.12.001.
• [18]Li X,Kramer MC,VAN DER Loos CM,et al.Early onset of endothelial cell proliferation in coronary thrombi of patients with an acute myocardial infarction:implications for plaque healing[J].J Thromb Haemost,2012,10(3):466-473. DOI:10.1111/j.1538-7836.2012.04620.x.
• [19]Baaten CCFMJ,Nagy M,Bergmeier W,et al. Platelet biology and function:plaque erosion vs. rupture[J].Eur Heart J,2024,45(1):18-31. DOI:10.1093/eurheartj/ehad720.
• [20]Kramer MCA,Rittersma SZ,de Winter RJ,et al.Relationship of thrombus healing to underlying plaque morphology in sudden coronary death[J].J Am Coll Cardiol,2010,55(2):122-132.DOI:10.1016/j.jacc.2009.09.007.
• [21]Souilhol C,Harmsen MC,Evans PC,et al.Endothelial-mesenchymal transition in atherosclerosis[J].Cardiovasc Res,2018,114(4):565-577. DOI:10.1093/cvr/cvx253.
• [22]Evrard SM,Lecce L,Michelis KC,et al.Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability[J].Nat Commun,2016,7:11853.DOI:10.1038/ncomms11853.
• [23]Mori M,Sakamoto A,Kawakami R,et al.CD163+macrophages induce endothelial-to-mesenchymal transition in atheroma[J].Circ Res,2024,135(2):e4-e23. DOI:10.1161/CIRCRESAHA.123.324082.
• [24]Rizzo S,Coen M,Sakic A,et al.Sudden coronary death in the young:evidence of contractile phenotype of smooth muscle cells in the culprit atherosclerotic plaque[J].Int J Cardiol,2018,264:1-6.DOI:10.1016/j.ijcard.2018.02.096.
• [25]Corrado D,Basso C,Poletti A,et al.Sudden death in the young.Is acute coronary thrombosis the major precipitating factor?[J].Circulation,1994,90(5):2315-2323. DOI:10.1161/01.cir.90.5.2315.
• [26]Nishi T,Kume T,Yamada R,et al.Layered plaque in organic lesions in patients with coronary artery spasm[J].J Am Heart Assoc,2022,11(7):e024880. DOI:10.1161/JAHA.121.024880.
• [27]Lee CH,Hsieh MJ,Liu KS,et al.Promoting vascular healing using nanofibrous ticagrelor-eluting stents[J].Int J Nanomedicine,2018, 13:6039-6048. DOI:10.2147/IJN.S166785.
• [28]Andreata F,Syvannarath V,Clement M,et al.Macrophage CD31signaling in dissecting aortic aneurysm[J].J Am Coll Cardiol,2018,72(1):45-57. DOI:10.1016/j.jacc.2018.04.047.
• [29]Caligiuri G.CD31 as a therapeutic target in atherosclerosis[J].Circ Res,2020,126(9):1178-1189. DOI:10.1161/CIRCRESAHA.120.315935.
• [30]Cao Q,Rong S,Repa JJ,et al.Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development[J].Arterioscler Thromb Vasc Biol,2014,34(9):1871-1879. DOI:10.1161/ATVBAHA.114.303393.
• [31]Mullican SE,Gaddis CA,Alenghat T,et al.Histone deacetylase3 is an epigenomic brake in macrophage alternative activation[J].Genes Dev,2011,25(23):2480-2488. DOI:10.1101/gad.175950.111.
• [32]Ouimet M,Ediriweera HN,Gundra UM,et al.MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis[J].J Clin Invest,2015,125(12):4334-4348. DOI:10.1172/JCI81676.
• [33]Lupieri A,Smirnova NF,Solinhac R,et al.Smooth muscle cellsderived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response[J].Cardiovasc Res,2020,116(2):438-449. DOI:10.1093/cvr/cvz122.
• [34]De Henau O,Rausch M,Winkler D,et al.Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells[J].Nature,2016,539(7629):443-447. DOI:10.1038/nature20554.
• [35]Mayer L,Sandborn WJ,Stepanov Y,et al.Anti-IP-10 antibody(BMS-936557)for ulcerative colitis:a phase Ⅱ randomised study[J].Gut,2014,63(3):442-450. DOI:10.1136/gutjnl-2012-303424.
• [36]Asada K,Saito Y,Takaoka H,et al.Relation of perivascular adipose tissues on computed tomography to coronary vasospasm[J].Rev Cardiovasc Med,2025,26(2):26327. DOI:10.31083/RCM26327.
• [37]West HW,Dangas K,Antoniades C.Advances in clinical imaging of vascular inflammation:a state-of-the-art review[J].JACC Basic Transl Sci,2023, 9(5):710-732. DOI:10.1016/j.jacbts.2023.10.007.
• [38]程治源,马文锐,潘子磊,等.冠状动脉原位原发病变经药物涂层球囊处理后未经治疗的遗留夹层临床结局[J].中国介入心脏病学杂志,2025,33(10):568-573. DOI:10.3969/j.issn.1004-8812.2025.10.004.
• [39]吴轶喆,钱菊英,殷嘉晟,等.首例薄壁生物可吸收支架(BIOMAGIC)治疗冠状动脉原位病变3年造影和临床结果[J].中国介入心脏病学杂志,2022,30(9):711-713. DOI:10.3969/j.issn.1004-8812.2022.09.015.
• [40]Stone GW,Maehara A,Ali ZA,et al.Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque[J]. J Am Coll Cardiol,2020,76(20):2289-2301. DOI:10.1016/j.jacc.2020.09.547.
• [41]van Veelen A,Kü??ük IT,Garcia-Garcia HM, et al. Paclitaxel-coated balloons for vulnerable lipid-rich plaques[J].EuroIntervention,2024,20(13):e826-e830. DOI:10.4244/EIJ-D-23-01073.